Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

被引：0
|
作者：
Thomas E. Stinchcombe
Mark A. Socinski
Christine M. Walko
Bert H. O’Neil
Frances A. Collichio
Anastasia Ivanova
Hua Mu
Michael J. Hawkins
Richard M. Goldberg
Celeste Lindley
E. Claire Dees
机构：
[1] University of North Carolina,Department of Hematology/Oncology, Developmental Therapeutics Group Lineberger Comprehensive Cancer Center
[2] University of North Carolina,School of Pharmacy
[3] Lineberger Comprehensive Cancer Center,Department of Biostatics
[4] Abraxis BioScience,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Dose-limiting toxicity; Maximum tolerated dose; Melanoma; Non-small-cell lung cancer; Small-cell lung cancer; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：759 / 766
页数：7
相关论文
共 50 条
  • [31] A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors
    Cohen, Adam L.
    Ray, Abhijit
    Van Brocklin, Matthew
    Burnett, David M.
    Bowen, Randy C.
    Dyess, Donna L.
    Butler, Thomas W.
    Dumlao, Theresa
    Khong, Hung T.
    ONCOTARGET, 2017, 8 (32) : 52413 - 52419
  • [32] Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial
    Ott, Patrick A.
    Chang, Jason
    Madden, Kathleen
    Kannan, Rajni
    Muren, Caroline
    Escano, Crystal
    Cheng, Xin
    Shao, Yongzhao
    Mendoza, Sandra
    Gandhi, Alex
    Liebes, Leonard
    Pavlick, Anna C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 183 - 191
  • [33] Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    Lee, Carrie B.
    Hayes, D. Neil
    Moore, Dominic T.
    Goldberg, Richard M.
    Dees, E. Claire
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) : 521 - 526
  • [34] Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial
    Patrick A. Ott
    Jason Chang
    Kathleen Madden
    Rajni Kannan
    Caroline Muren
    Crystal Escano
    Xin Cheng
    Yongzhao Shao
    Sandra Mendoza
    Alex Gandhi
    Leonard Liebes
    Anna C. Pavlick
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 183 - 191
  • [35] A phase II trial of carboplatin and ABI-007 in patients with unresectable stage IV melanoma, N057E
    Kottschade, L. A.
    Suman, V. J.
    Amatruda, T., III
    McWilliams, R. R.
    Dakhil, S. R.
    Nikcevich, D. A.
    Morton, R. F.
    Fitch, T. R.
    Jaslowski, A. J.
    Markovic, S. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
    Vlahovic, Gordana
    Karantza, Vassiliki
    Wang, Ding
    Cosgrove, David
    Rudersdorf, Nikita
    Yang, Jianning
    Xiong, Hao
    Busman, Todd
    Mabry, Mack
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (05) : 976 - 984
  • [37] A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
    Gordana Vlahovic
    Vassiliki Karantza
    Ding Wang
    David Cosgrove
    Nikita Rudersdorf
    Jianning Yang
    Hao Xiong
    Todd Busman
    Mack Mabry
    Investigational New Drugs, 2014, 32 : 976 - 984
  • [38] A phase I study investigating the combination of orally bioavailable platinum and nanoparticle albumin-bound paclitaxel in advanced solid tumors
    Deshpande, H. A.
    Gettinger, S.
    Rowen, E.
    Abu-Khalaf, M. M.
    Clarke, J.
    Burns, A. J.
    Kelly, W. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Thompson, Dana S.
    Mohyuddin, Adil
    Bendell, Johanna C.
    Yardley, Denise A.
    Burris, Howard A., III
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 471 - 475
  • [40] A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
    Suzanne F. Jones
    Jeffrey R. Infante
    Dana S. Thompson
    Adil Mohyuddin
    Johanna C. Bendell
    Denise A. Yardley
    Howard A. Burris
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 471 - 475
12345